Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 11.02.2022

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31.12.2021. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31.12.2021 is enclosed herewith. 2. Appointed M/s. SAV & Associates LLP as Secretarial Auditor for the financial year 2021-22 for the purpose of conducting Secretarial Audit. 3. A Risk Management Committee of the Company has been constituted. 4. The Board has formulated a Dividend Distribution Policy. 5. The Board of Directors took note of the following: a) The tenure of appointment of Mrs. Jayshree D Patel, Whole Time Director ends on 27.03.2022 b) Mrs. Jayshre D. Patel will not be seeking reappointment. c) Mrs. Jayshree D. Patel will be stepping down as Director w.e.f. closure of business hours on 27.03.2022 This may be taken as compliance under the Listing Regulations.
11-02-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Intimation Of Date Of Board Meeting & Closure Of Trading Window

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Friday, 11th February, 2022 inter alia, to consider, the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2021. Further, in continuation of our Letter dated 29th December 2021, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Saturday, 01st January, 2022, which shall remain closed till the closure of trading hours on 13th February, 2022 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time. This is for your information and record.
31-01-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
11-01-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
11-01-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform with reference to our letter dated December 27, 2021, regarding One-on-One Meeting with Analysts / Investors which was scheduled today, stands cancelled, and the next date of schedule will be intimated as and when finalized.
30-12-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1st January, 2022 and will re-open after completion of 48 hours from the declaration of financial results for the quarter and 31.12.2021 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter and nine months ended 31.12.2021 shall be intimated in due course.
29-12-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company will meet with Analysts/Investors on Thursday, 30th December 2021; the details of the same are given below: Sr. no. Name Venue 1 Bellwether Capital Mumbai Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
27-12-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement Under Regulation 30(LODR)-Update(Incorporation Of New Subsidiary)

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has incorporated a new Subsidiary Company incorporated under the Companies Act 2006 as a private Company, that the Company is limited by shares, and the situation of its registered office is in England and Wales. Name of the new Subsidiary Company: 'CARPO INVESTMENTS LTD' Date of Incorporation: December 22, 2021. This is for the information of the exchange and the members.
23-12-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Credit Rating

 We hereby inform you that Credit Rating assigned to the Company by the Credit Rating Agency i.e Acuite Ratings & Research Limited as under: Product Initial Quantum (Rs. Cr.) Net Quantum (Rs. Cr) Long Term Rating Short Term Rating Bank Loan Ratings 63.25 63.25 ACUITE A3 / Assigned Bank Loan Ratings 25.85 25.85 ACUITE BBB- / Stable / Assigned Total - 89.10 - - This is for your information and record.
09-12-2021
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company hada one-on-one conference callwithAnalysts/Investors on Wednesday, 1stDecember2021; the details of the same are given below: Sr. no. Name Venue 1 Lucky Securities Zoom Conference Call Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
01-12-2021
Next Page
Close

Let's Open Free Demat Account